Entering text into the input field will update the search result below

CytomX misses by $0.11, beats on revenue

Nov. 07, 2017 5:12 PM ETCytomX Therapeutics, Inc. (CTMX) StockBy: Niloofer Shaikh, SA News Editor
  • CytomX (NASDAQ:CTMX): Q3 EPS of -$0.28 misses by $0.11.
  • Revenue of $24.14M (+599.7% Y/Y) beats by $6.65M.
  • Press Release

Recommended For You

More Trending News

About CTMX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CTMX--
CytomX Therapeutics, Inc.